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Human RORC+ lymphoid tissue inducer cells are part of a rapidly expanding family of
innate lymphoid cells (ILC) that participate in innate and adaptive immune responses as
well as in lymphoid tissue (re) modeling. The assessment of a potential role for innate
lymphocyte-derived cytokines in human homeostasis and disease is hampered by a poor
characterization of RORC+ innate cell subsets and a lack of knowledge on the distribution
of these cells in adults. Here we show that functionally distinct subsets of human RORC+
innate lymphoid cells are enriched for secretion of IL-17a or IL-22. Both subsets have an
activated phenotype and can be distinguished based on the presence or absence of the
natural cytotoxicity receptor NKp44. NKp44+ IL-22 producing cells are present in tonsils
while NKp44− IL-17a producing cells are present in fetal developing lymph nodes. Devel-
opment of human intestinal NKp44+ ILC is a programmed event that is independent of
bacterial colonization and these cells colonize the fetal intestine during the ﬁrst trimester.
In the adult intestine, NKp44+ ILC are the main ILC subset producing IL-22. NKp44− ILC
remain present throughout adulthood in peripheral non-inﬂamed lymph nodes as resting,
non-cytokine producing cells. However, upon stimulation lymph node ILC can swiftly initi-
ate cytokine transcription suggesting that secondary human lymphoid organsmay function
as a reservoir for innate lymphoid cells capable of participating in inﬂammatory responses.
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INTRODUCTION
There is an increasing awareness that early innate response involve
several types of RORC+ and RORC− lymphoid-like cells that
combine aspects of innate and adaptive immunity including
the production of cytokines traditionally associated with adap-
tive immune cells. These innate cells are collectively referred to
as innate lymphocytes (ILC) and are on the one hand impor-
tant in early immunity to pathogenic bacteria and helminthes
as well as tissue integrity after infection, while these cells on
the other hand can be part of pathology during experimental
colitis and are speciﬁcally expanding in Crohn’s disease patients
and allergic rhinosinusitis patients (Satoh-Takayama et al., 2008;
Sanos et al., 2009; Buonocore et al., 2010; Moro et al., 2010;
Neill et al., 2010; Mjosberg et al., 2011; Spits and Di Santo,
2011).
The best studied population of RORC+ ILC are lymphoid tis-
sue inducer cells (LTi cells) that are present in secondary lymphoid
organs andwhoseprime function is to control fetal developmentof
lymphnodes andPeyer’s patches inmouse andman (Cupedo et al.,
2009; van de Pavert and Mebius, 2010). Even though lymphoid
organogenesis occurs in utero, cells that phenotypically resemble
LTi cells have been found in adult mice (Mebius et al., 1997; Kim
et al., 2006). Similar to fetal LTi cells, adult cells express mole-
cules involved in LN development such as lymphotoxinα1β2 (LT)
and TNFα and depend on expression of Rorγt and Id2 for their
development (Yokota et al., 1999; Kurebayashi et al., 2000; Sun
et al., 2000; Kim et al., 2006).Although it remains to be determined
to what extent adult LTi cells are similar to their fetal counterparts
in terms of the ability to induce lymphoid organs, adult LTi cells
were shown to have additional functions in the support of adaptive
immune responses by facilitating memory T cell generation in the
spleen (Kim et al., 2003; Lane et al., 2008). In humans, ILC that
resemble the mouse LTi cells are present in developing fetal lymph
nodes (Cupedo et al., 2009). In adult mice and humans, RORC+
ILC are found in secondary lymphoid organs, in the skin, and in
the intestines. In mice, RORC+ ILC are essential for the ﬁrst wave
of defense against attaching and effacing intestinal pathogens like
Citrobacter rodentium (Cella et al., 2008; Satoh-Takayama et al.,
2008). IL-22 produced by ILC activates the epithelium via the IL-
22 receptor to produce antimicrobial products (Cella et al., 2008;
Ouyang et al., 2008; Satoh-Takayama et al., 2008). In humans, sev-
eral mucosal ILC subsets that produce IL-22 were described. We
have previously identiﬁed a population of CD56+RORC+ ILC
in the tonsil that constitutively produce IL-22 (Cupedo et al.,
2009). At the same time, a population of NKp44+RORC+ ILC
were described in tonsils, Peyer’s patches, and small intestines
and named NK22 (Cella et al., 2008). Clonal analysis of tonsil-
derived RORC+ ILC has since shown that CD56+RORC+ ILC
and NKp44+ NK22 cells are the same population of ILC (Crellin
et al., 2010).
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NKp44 belongs to a family of activating receptors found on
human NK cells. These receptors are collectively termed natural
cytotoxicity receptors (NCRs) and next to NKp44 include NKp30
and NKp46 (Moretta et al., 2001). All three are Ig-like trans-
membrane receptors that convey activating signals to NK cells.
NKp46 and NKp30 are expressed constitutively, while expression
of NKp44 is induced upon NK cell activation. NKp46 is also
expressed on mouse NK cells, as well as on mouse ILC in the
intestines. NKp30 and NKp44 are not expressed in Mus musculus
(Moretta et al., 2001; Hollyoake et al., 2005).
Besides production of IL-22, RORC+ ILC in mice and man
have been reported to produce IL-17a. In man, RORC+ ILC in
fetal lymph nodes (Cupedo et al., 2009) and inﬂamed intestines
(Geremia et al., 2011) contain IL-17a transcripts and in mice,
stimulated splenic RORC+ ILC and RORC+ ILC from the small
intestines were shown to produce IL-17a (Takatori et al., 2009;
Sawa et al., 2011).
In sum, RORC+ ILC from tonsils and fetal lymph nodes differ
strikingly in cytokine production: tonsil ILC produce IL-22 while
fetal lymph node ILC contain only transcripts for IL-17a (Cupedo
et al., 2009). Whether in vivo IL-17 and IL-22 are produced by the
same population of cells or by different ILC populations is still
subject to debate (Sawa et al., 2010;Vonarbourg et al., 2010). Clar-
ifying the cellular sources of these functionally distinct cytokines
will increase our understanding of ILC biology and activation. In
this reportwedetermined the cellular source of ILC-derived IL-17a
and IL-22 and show that these cytokines are preferentially tran-
scribed by distinct subsets of ILC located in peripheral or mucosal
lymphoid organs respectively.
RESULTS
DIFFERENTIAL NCR EXPRESSION ON TONSIL- AND FETAL LN-DERIVED
ILC
Wehypothesized that expressionof NaturalCytotoxicityReceptors
could be used to distinguish ILC subpopulations biased toward
production of either IL-17a or IL-22. To test this we ﬁrst com-
pared the ex vivo expression of NKp30, NKp44, and NKp46 on
freshly isolated human ILC from fetal lymph nodes vs tonsils.
The following phenotypic deﬁnition was used for ILC: lineage
(CD3; CD19; CD14; CD34) negative cells expressing intermedi-
ate levels of CD45 and high levels of both CD127 (IL7Rα) and
CD117 (c-Kit). Cells within this gate were uniformly RORC posi-
tive (Figure 1A). In fetal lymph nodes, the majority of RORC+
ILC lacked expression of NKp46 (Figure 1B). Approximately
half of the cells expressed NKp30 and a very small fraction of
these NKp30+ ILC co-expressed NKp44 (Figure 1B). In con-
trast, themajority of tonsil-derived RORC+ ILC expressed NKp44
as well as NKp30. In addition, a substantial fraction of tonsil
RORC+ ILC expressed NKp46 (Figure 1B). The biggest differ-
ences in NCR expression between fetal lymph node and tonsils
were observed for NKp44 and upon enumeration the percent-
age of NKp44-expressing RORC+ ILC was indeed signiﬁcantly
increased in tonsils compared to fetal lymph nodes (Figure 1C).
These data show that the relative distribution of NCR-positive
vs NCR-negative ILC is different between tonsils and fetal lymph
nodes and follows the pattern described for IL-22 (Cupedo et al.,
2009).
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FIGURE 1 | NCR expression on ILC from fetal LN and tonsil.
(A) Lineage-negative cells in fetal lymph nodes, fetal spleen, and tonsil
labeled for CD117 and CD127 are RORC positive. Shaded histogram
indicates isotype control staining (representative example of three
independent experiments). (B) Flow cytometric analysis of NKp30
(p =0.07), NKp44 (p =0.00), and NKp46 (p =0.03) expression on ILC and
fetal lymph nodes and tonsil. (C) Percentage of NKp30, NKp44, and NKp46
expressing RORC+ ILC in fetal lymph nodes and tonsil (n>5; average±SD.)
Next, we assessed the proportion of CD56 expressing ILC in
fetal lymph nodes and tonsils. The percentage of CD56+RORC+
ILC was low in fetal lymph nodes, but was increased in ton-
sils where on average half of the RORC+ ILC expressed CD56
(Figure 2A). This implies that CD56 expression follows a pattern
similar but not identical to NKp44, and indeed in tonsils only half
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FIGURE 2 | CD56 expression on ILC from fetal LN and tonsil.
(A) Percentage of CD56 expressing RORC+ ILC in fetal lymph nodes and
tonsil (n>5; Av±SD, p =0.007). (B) Flow cytometric analysis of CD56 and
NKp44 expression on RORC+ ILC in fetal lymph nodes and tonsil
(representative example of ﬁve independent experiments).
of the NKp44+ ILC population expressed CD56 (Figure 2B). In
summary, NKp44, and not CD56, is the most prominent cell sur-
face marker differentiating between RORC+ ILC from fetal lymph
nodes and adult tonsils.
NKp44 EXPRESSION ALLOWS IDENTIFICATION OF IL-17 AND IL-22
BIASED ILC
On NK cells, NKp44 is only expressed upon activation. In addi-
tion, production of IL-17a in T cells is restricted to activated or
memory cells (Fossiez et al., 1996). This led us to hypothesize
that ILC which contain transcripts for either IL17A or IL22 might
also be cells with an activated phenotype. To test this hypothesis,
we analyzed the expression of surface proteins known to be reg-
ulated during cellular activation on RORC+ ILC cells from fetal
lymph nodes and tonsils. The early activation marker CD69 was
expressed on part of RORC+ ILC, and the combination of CD69
with NKp44 revealed discrete ILC subpopulations (Figure 3A). In
fetal lymph nodes, where the majority of cells lack expression of
NKp44, CD69 divided the ILC population into a CD69− and a
CD69+ population. In tonsils, NKp44+ ILC were most abundant,
and all NKp44+ cells co-expressed CD69. In addition, a small
population of CD69+NKp44− cells was present (Figure 3A).
We next set out to determine the presence of IL22 and IL17A
transcripts in these ILC subpopulations. To this end, the NKp44−
ILC were sorted from fetal lymph nodes and separated in CD69−
and CD69+ populations. From tonsils, ILC were puriﬁed and
divided in NKp44− and NKp44+ fractions. Transcripts for IL17A
and IL22 were determined without ex vivo stimulation. Within
the fetal lymph nodes, IL17A transcripts were enriched within
the CD69+NKp44− population (Figure 3B, top right). IL22 tran-
scripts were very low to absent in the fetal lymphnodes (Figure 3B,
top left). In tonsil RORC+ ILC, IL22 transcripts were easily
detectable within the CD69+NKp44+ population as expected
(Cella et al., 2008) butweremuch lower in theNKp44− population
(Figure 3B, bottom left). Transcripts for IL17A were undetectable
in tonsil ILC (Figure 3B, bottom right).
In order to assess whether the divergent cytokine patterns
observed directly ex vivo are maintained after in vitro stimulation
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FIGURE 3 | Differential cytokine production by NKp44+ and NKp44−
ILC. (A) Flow cytometric analysis of CD69 and NKp44 expression on
RORC+ ILC from fetal LN and tonsil (representative example of three
independent experiments). (B) Expression of IL22 and IL17A mRNA in
sorted ILC populations from tonsils and fetal LN (representative of two
individual experiments with three to ﬁve donors per experiment). (C) IL-22
protein production by NKp44− and NKp44+ ILC from tonsils stimulated
overnight with PMA+ ionomycin (n=3).
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we isolated tonsil NKp44+ and NKp44− ILC and stimulated these
overnight with PMA and ionomycin. Similar to freshly isolated
ILC, overnight stimulation induces IL-22 secretion from NKp44+
ILC, but not NKp44− ILC (Figure 3C), conﬁrming the cytokine
bias seen directly ex vivo. The IL22 induction in NKp44+ ILC by
PMA/ionomycin stimulation was observed in all donors analyzed,
but did however show a high degree of variability.
These ﬁndings imply that tonsil-derived NKp44 positive
ILC preferentially transcribe IL-22, while IL-17 is preferentially
transcribed by fetal lymph node-derived NKp44+CD69+ ILC,
enriched within the ILC that lack expression of NKp44, but do
express CD69.
HUMAN MUCOSAL NKp44+ ILC ARE DEVELOPMENTALLY
PROGRAMMED
In the mouse, NKp46+ ILC develop in the absence of microbiota,
and appear in the intestines after birth (Sanos et al., 2009; Sawa
et al., 2010; Reynders et al., 2011). Since fetal human intestines
are not yet colonized by bacteria or exposed to ingested anti-
gens (DiGiulio et al., 2008; Mshvildadze et al., 2010; Agarwal
et al., 2011), this allowed us to asses the development of human
fetal NKp44+ ILC in the absence of external stimuli. We ana-
lyzed ILC in ﬁrst and second trimester fetal small intestines and
determined their expression of CD69 and NKp44. First trimester
small intestinal-derived ILC (7weeks gestation) did not express
CD69 or NKp44 and resembled putative LTi cells (Figure 4A).
CD69+NKp44+ ILC appeared during late ﬁrst trimester, between
weeks 7 and 10 of gestation and with increasing age replaced
the LTi-like cells. From week 12 onward, the majority of ILC
in the small intestines were expressing both CD69 and NKp44
(Figure 4B). This was speciﬁc for the fetal small intestines and
was not found in paired mesentery samples containing develop-
ing lymph nodes (Figure 4C). Since our analysis of NKp44+ ILC
from tonsils had shown IL22 transcription in these cells, we also
probed fetal intestine-derived NKp44+ ILC for IL22 transcripts.
We consistently found low levels of IL-22 transcripts in NKp44+
ILC from second trimester fetal small intestines (Figure 4D). It
was technically impossible to purify sufﬁcient NKp44− ILC from
fetal intestines as a comparison. Therefore, CD56+CD127+ NK
cells sorted from fetal lymph nodes were used as a negative con-
trol. These data show that human NKp44+ ILC develop in utero
in the absence of microbial colonization and can be found in the
small intestine.
To be able to compare intestinal NKp44+ and NKp44− ILC
we next isolated these cells from non-affected adult ileal mucosa
acquired during resection procedures for colon cancer. In the adult
human intestine, the majority of ILC express NKp44 (Figure 4E).
In line with our data from tonsil-derived ILC, intestinal NKp44+
ILC preferentially transcribe IL-22, while NKp44− ILC only
contain very low levels of IL-22 trancripts (Figure 4F).
RESTING ILC ARE PRESENT IN ADULT NON-INFLAMED HUMAN LYMPH
NODES
The presence of IL-17 transcribing ILC in fetal human lymph
nodes raised the question whether these cells might also be found
in adult-lymph nodes. Therefore we determined the presence
of RORC+ ILC in adult peripheral non-inﬂamed lymph nodes.
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FIGURE 4 | Human NKp44+ ILC are developmentally programmed.
(A) Flow cytometric analysis of ILC from fetal intestines of indicated ages
(weeks gestation) (representative examples of at least three independent
experiments per time point). (B) percentage of ILC expressing NKp44 in the
fetal small intestine during ﬁrst trimester (<12weeks) or second trimester
(>12weeks) (n>6; average±SD; p =0.003). (C) Flow cytometric analysis
of ILC in fetal small intestines and mesentery of the same donor at
12weeks gestation (representative example of three independent
experiments). (D) Expression of IL22 transcripts in NKp44+ ILC from fetal
intestine compared to NK cells from fetal lymph node (ﬁve independent
samples per condition, average±SD; p =0.009). (E) Flow cytometric
analysis of NKp44 expression on ILC from adult intestine. Filled histogram
shows isotype control staining (representative example of ﬁve independent
experiments). (F) Expression of IL22 transcripts in NKp44+ and NKp44− ILC
from adult intestine (n=7, average±SD; p =0.005).
Lymph nodes were collected during multi-organ donation proce-
dures and were liver-draining hepatic lymph nodes unless stated
otherwise. Donor age ranged from 24 to 68 years. In adult-lymph
nodes a population of Lineage−CD45intCD117+CD127+ ILCwas
found that uniformly expressed RORC (Figure 5A). Based on
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FIGURE 5 | NKp44− ILC in adult non-inflamed lymph nodes. (A) Flow
cytometric analysis of ILC from adult hepatic lymph nodes for expression of
RORC, NKp44, NKp30, NKp46, and CD56 (representative example of three
independent experiments). (B) Flow cytometric analysis of CD69 and NKp44
expression on ILC from adult hepatic and inguinal lymph nodes
(representative example of at least three independent experiments).
(C) Percentage of NKp30, NKp44 and NKp46 expressing RORC+ ILC in fetal
lymph nodes, adult-lymph nodes and tonsil (representative example of at
least three independent experiments). (D) PCR analysis for IL17A and (E) IL22
transcripts of sorted ILC from adult hepatic lymph nodes compared to
NKp44− and NKp44+ ILC from tonsil (adult LN vs NKp44− p =0.02; adult LN
vs NKp44+ p =0.02; n=4).
expression of NCRs, adult LN-derived RORC+ ILC resembled ILC
from fetal lymph nodes rather then from tonsils in that they were
mostly negative for NKp46 and NKp44 and only a part of the
cells expressed CD56 and NKp30 (Figures 5A,B). There was no
difference in the percentage of NKp30 or NKp44-expressing ILC
between fetal and adult LN,while slightlymore adult ILCexpressed
NKp46 (Figure 5B). These data show that NKp30 is the only NCR
that is consistently expressed on approximately half of all ILC,
regardless of whether they were isolated from fetal LN, adult LN
or tonsil.
Upon staining for CD69, the presence of CD69+ and CD69−
ILC became apparent, very much alike the fetal LN-derived
ILC. This phenotype was not restricted to hepatic lymph nodes
as a similar distribution of NCR was seen in adult inguinal
www.frontiersin.org April 2012 | Volume 3 | Article 72 | 5
Hoorweg et al. Subsets of innate lymphoid cells
nodes (Figure 5C). To determine cytokine production by the
ILC from adult-lymph nodes, total NKp44− ILC were puriﬁed
and analyzed for IL22 and IL17A transcripts directly ex vivo.
Transcript levels for these cytokines were compared to the lev-
els found in NKp44− and NKp44+ ILC from tonsil. Strikingly,
adult-lymph node ILC lacked detectable IL22 or IL17A tran-
scripts (Figures 5D,E). These data suggest that, in contrast to
fetal lymph node-derived ILC, adult non-inﬂamed lymph node-
derived ILC are not actively transcribing detectable levels of IL17A
in vivo.
To test whether these peripheral ILC were biased toward the
production of either IL17A or IL22 upon activation, we stimu-
lated adult-lymph node ILC overnight with PMA and ionomycin
(Figure 6). After overnight stimulation we could detect low lev-
els of both IL17A and IL22 transcripts in adult ILC. Induction of
IL-17 was speciﬁc for adult-lymph node ILC as tonsil-derived ILC
did not contain IL17A transcripts after stimulation (Figure 6A).
However, the levels of IL17A transcripts were much lower then
those found in freshly isolated fetal LN-derived CD69+ ILC. Even
more so, the IL22 transcripts found in adult ILC after overnight
stimulation were very low in comparison to the levels found in
either stimulated or unstimulated tonsil ILC. These ﬁndings indi-
cate that throughout adulthood human lymph nodes contain a
resting ILC population that is characterized by the absence of
NKp44 and the absence of active transcription of IL17A or IL22.
Finally, IL-17a and IL-22 protein levels produced by adult-
lymph node-derived NKp44− ILC stimulated with physiological
stimuli were determined by ELISA. Unfortunately, the scarcity of
adult human tissue precluded the analysis of sufﬁcient donors to
draw statistical conclusions. This notwithstanding, in two inde-
pendent donors 3 days culture in the presence of either IL-23 or
IL-1β did induce detectable levels of IL-22 protein (Figure 6C).
These culture conditions did not induce IL-17a secretion to lev-
els detectable by our ELISA (detection limit= 31 pg/ml; data not
shown). This suggests that even though low level transcription of
IL17A can be initiated, no detectable protein is secreted. The rea-
son for this is presently unknown. These data suggest that resting
adult-lymph node-derived ILC retain the capacity to secrete IL-22
upon in vitro stimulation with IL-23 or IL-1β. Further work is
needed to substantiate these ﬁndings.
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FIGURE 6 | Stimulated adult CD69+NKp44− ILC produce IL-22. (A) IL17A
transcripts in NKp44− ILC from adult hepatic lymph nodes and in NKp44+ ILC
from tonsils stimulated overnight with PMA+ ionomycin as well as in freshly
isolated fetal LN-derived CD69+ ILC (n=3). (B) IL22 transcripts NKp44− ILC
from adult hepatic lymph nodes and in NKp44+ ILC from tonsils stimulated
overnight with PMA+ ionomycin (n=3). (C) IL-22 protein production by
CD69−NKp44− ILC from adult hepatic lymph nodes after 3 days culture with
IL-23 or IL-1β (n=2).
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DISCUSSION
RORC+ ILC are increasingly recognized as important mediators
of early innate immunological defenses againstmucosal pathogens
and as essential for safeguarding tissue integrity during infections.
Both effects are mediated by ILC-derived cytokines, and especially
IL-22 and IL-17a have been studied in this respect. In mice, IL-22
secreting ILC mediate the innate response to C. rodentium and
IL-22 is an important mediator of epithelial homeostasis (Vivier
et al., 2009). Conversely, IL-17a producing ILC are pathogenic
in a T cell-independent mouse model of intestinal inﬂammation
(Buonocore et al., 2010). Most importantly, the balance between
IL-22 and IL-17a secreting ILCwas shown to be skewed toward IL-
17a in patients with Crohn’s disease, suggesting that ILC-derived
cytokines might be involved in human disease (Geremia et al.,
2011).
The systematic analysis of ILC subsets in humans and the detec-
tion of any changes in subset distribution as a result of disease
are hampered by the poor characterization of functionally dis-
tinct human ILC. In this study we show that expression of the
NCR NKp44 is a good predictor for ILC that are actively tran-
scribing IL-22, and that these cells are mainly found in mucosal
tissues. In contrast, our data suggest that throughout adulthood,
non-inﬂamed lymph nodes may function as a reservoir of resting,
RORC+ non-cytokine secreting ILC that lack NKp44 expression,
yet retain the capacity to secrete IL-22 after appropriate cytokine
activation in vitro.
Production of IL-17a by T cells is normally tightly controlled
to avoid unwanted or excessive inﬂammation (Eyerich et al.,
2010) and the fact that freshly isolated CD69+NKp44− ILC in
non-inﬂamed lymph nodes lack IL17A transcripts suggests that
similar levels of restraint are operational for ILC. Unraveling the
exact signals that can either induce or inhibit ILC activation is
needed to understand regulation and control of innate IL-17
secretion.
IL-17a has been associated with several human diseases
(Ouyang et al., 2008) and ILC-derived IL-17a has been reported in
experimental models of colitis (Buonocore et al., 2010). In addi-
tion, an increase in IL-17 producing ILC has now also been found
in the intestines of some Crohn’s disease patients (Geremia et al.,
2011). The IL-17 producing ILC in Crohn’s disease patients were
mainly found within the CD56− ILC fraction, while the CD56+
ILC were more prominent producers of IL-22 (Geremia et al.,
2011). Our current data would predict that a dissection based on
NKp44 expression, rather then expression of CD56, could further
enhance the exact enumeration of IL-22 vs IL-17a producing ILC
in humans.
The biological function of IL-17a produced by fetal LN-derived
ILC remain enigmatic.Development of lymphoidorganshasmany
similarities to a controlled inﬂammation and the inﬂammation-
related cytokine IL-17a would ﬁt that concept (Nishikawa et al.,
2000; Drayton et al., 2006). However, IL-17a is unlikely to have an
essential function during organogenesis as IL-17Rα deﬁcient mice
display no gross abnormalities in LN development (Kerim Hoor-
weg and TomCupedo, unpublished observations), suggesting that
IL-17a serves another yet to be determined function.
In vivo, distinct subsets of RORC+ ILC seem biased toward
either IL17A (CD69+NKp44− ILC) or IL22 (CD69+NKp44+
ILC) transcription. It is not clear whether these subsets belong
to different ILC lineages, or whether they represent different acti-
vation or differentiation states of cells within a single lineage. In
mice, conﬂicting data exists on the relationship between NKp46+
and NKp46− ILC. Genetic approaches indicated that these two
cell types belong to separate lineages and do not have a precursor–
progeny relationship (Sawa et al., 2010). Conversely, transfer of
puriﬁed populations of ILC showed that NKp46− cells could
give rise to NKp46+ ILC in vivo (Vonarbourg et al., 2010). In
humans, these relationships are even less clear. After in vitro
culture, freshly isolated NKp44− fetal LN-derived ILC acquired
NKp30, NKp44, and NKp46 (Cupedo et al., 2009). In line with
this, the adult-lymph node-derived ILC also upregulate NKp44
when cultured (Kerim Hoorweg and Tom Cupedo, unpublished).
Whether the observed IL-22 production by lymph node ILC is
functionally linked to this expression of NKp44 is currently under
investigation. Our current results indicate that in ex vivo iso-
lated ILC, NKp44 predicts for IL-22 production whereas in mice
NKp46 is a marker for IL-22 producing ILC, again adding to the
complexity of comparing data gathered in human and mouse
studies.
NKp44+ ILC are preferentially found in mucosal tissues like
tonsil and the intestines (this report and Cella et al., 2008).Within
thismucosal environmentNKp44+ ILC constitutively produce IL-
22 that, based on mouse models, acts on intestinal epithelial cells
and conditions these cells to cope with the hostile environment to
which they are exposed (Satoh-Takayama et al., 2008; Sanos et al.,
2009; Vivier et al., 2009).
Here we show that the appearance of ILC in the human intes-
tine is developmentally programmed andNKp44+ ILC are present
from early second trimester. In mice NKp46+ ILC is also a pro-
grammed event independent of microﬂora, yet these cells only
appear after birth (Sawa et al., 2010; Reynders et al., 2011). The
observed differences betweenmouse andman in this respectmight
be due to the longer pregnancy in humans. NKp44+ ILC in the
developing human intestine initiate low level IL22 transcription
during second trimester pregnancy. However, these IL22 levels
are much lower then those found in NKp44+ ILC from pediatric
tonsils or adult intestines. Current it is unknown whether this dif-
ference reﬂects a role for microbial colonization of the intestines
in inducing a postnatal increase in IL-22 levels. This would be
different from the observations done in mice, where microbial
colonization was not essential for IL-22 induction but actually
induces a decrease in intestinal IL-22 postnatal (Sawa et al., 2010,
2011; Reynders et al., 2011). Again, an alternative and perhaps
more likely explanation is that due to the longer gestation time
in humans compared to mice, the low levels of IL22 transcription
found during the second trimester will steadily increase through-
out the third trimester, reaching levels comparable to postnatal
ILC just before birth. Even thought the intestines are culture ster-
ile, they are by no means devoid of potential immune stimuli such
as TLR ligands and cytokines and these could still be a factor in
ILCdevelopment and activation (Mshvildadze et al., 2010;Agarwal
et al., 2011).
NKp44− ILC reside within peripheral lymph nodes through-
out life but in the absence of activating signals do not transcribe
detectable levels of IL17A or IL22. However, upon stimulation
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NKp44− ILC can produce at least IL-22, and also initiate low
level IL17A transcription. This raises the hypothesis that sec-
ondary lymphoid organs are a reservoir for ILC that canparticipate
in inﬂammatory responses in an antigen independent manner.
Detailed analysis of human lymph node biopsies from inﬂamma-
tory diseases or the study of relevant animal models is needed
to determine the contribution of LN-derived ILC to systemic
immune responses.
MATERIALS AND METHODS
HUMAN TISSUES
The use of all human tissues was approved by the Medical Ethical
Commission of the Erasmus University Medical Center Rotter-
dam, and use was contingent on informed consent. Fetal tissues
were obtained from elective abortions and gestational age was
determined by ultrasonic measurement of the diameter of the
skull or the femur and ranged from 7 to 22weeks gestation. Ton-
sils were obtained from routine pediatric tonsillectomies. Adult
hepatic and inguinal lymph nodes were collected post-mortem
during multi-organ donation procedures. Adult small intestine,
ileum, was collected as residual material after intestinal surgery
for colon carcinoma. Healthy ileum was obtained from a clear
distance from the tumor. Patients undergoing radiotherapy or
chemotherapy were excluded. Informed consent was obtained
from all patients, according to the Medical Ethical Commission
of the Academic Medical Center, Amsterdam, the Netherlands.
CELL PREPARATION
Fetal lymph nodes were dissected from the mesentery using dis-
secting microscopes, and cell suspensions were prepared by diges-
tion with 0.5mg/ml collagenase type IV (Sigma, St. Louis, MO,
USA) in PBS for 30min at 37˚C, while stirring continuously, and
subsequently ﬁltered through a 70-μm nylon mesh. Tonsils and
adult-lymph nodes were cut into small pieces and cell suspensions
werepreparedbydisrupting the tissuewith aGentleMacs (Miltenyi
Biotech) in the presence of 0.5mg/ml collagenase type IV (Sigma,
St. Louis, MO, USA). Mononuclear cells were isolated from ﬁcoll
gradients. Tonsils were further enriched for ILC by labeling with
CD117microbeads (Miltenyi Biotech) and positive selection using
MidiMacs (Miltenyi Biotech).
Adult intestinal ILC were isolated as described (Ruijter et al.,
2009) ileum was incubated with HBSS (Gibco) containing DTT
(154μg/ml), 0.1% β-mercaptoethanol, and 5mM EDTA at 37˚C
to eliminate mucus and epithelial cells. Thereafter mucosa was cut
into small pieces and digested for 30min at 37˚Cwith Liberase TM
(125μg/ml) and DNaseI (200μg/ml; Roche). Cell suspensions
were ﬁltered through a 70-μm nylon mesh and lamina propria
mononuclear cells (LPMC) were isolated by Ficoll-Paque PLUS
(GE, Healthcare).
FLOW CYTOMETRY
The following antibodies were used: CD117–PercP.Cy5.5,NKp44–
AlexaFluor647, NKp46–AlexaFluor647, NKp30–Pe (Biolegend,
San Diego, CA, USA); CD127–APC-eFluor780, CD45–PeCy7,
RORγt-Pe (eBioscience, San Diego, CA,USA); CD56–Paciﬁc Blue,
CD69–Pe, CD19–PeDY590, CD3–PeDY590, CD14–PeDY590, and
CD34–PeDY590 (Exbio, Praha, CZ, USA). Flow cytometry was
performed on a BD LSRII and cell sorting on a BD ARIA (Becton
Dickinson). Analysis were performed using FlowJo software (Tree
Star Inc., Stanford, CA, USA).
CELL CULTURE
Sorted ILC subsets were cultured overnight in the presence of IL-
7 (Peprotech) and SCF R&D Systems; both at 10 ng/ml) in the
presence or absence of PMA (50 ng/ml; Sigma) and Ionomycin
(100 ng/ml; Sigma) or for 3 days with IL-7, SCF, and either IL-23
or IL-1b. Cells were cultured in 200μl DMEM supplemented with
10% FCS (Hyclone). IL-17a and IL-22 production was measured
using the DuoSet ELISA development kit (R&D systems). ELISAs
were performed according to the manufacturers’ instructions.
PCR
From fetal samples, adult-lymph nodes, and tonsil, RNA was
extracted using the RNA-XS kit (Machery Nagel) followed by
reverse-transcription with random hexamer primers. For quan-
titative PCR, a Neviti Thermal Cycler (Applied Biosystems) and
DyNAmo Flash SYBR Green qPCR kit (Finnzymes) were used,
with the addition of MgCl2 to a ﬁnal concentration of 4mM. All
reactions were done in duplicate and are normalized to the expres-
sion of GAPDH (glyceraldehyde phosphate dehydrogenase). Rel-
ative expression was calculated by the cycling threshold (CT)
method as 2−Δt .
Primers used were:
GAPDH (Accession: NG_007073.2) FW GTC GGA GTC AAC
GGA TT; Rev AAG CTT CCC GTT CTC AG
IL22 (Accession:NM_020525.4) FWCCCATCAGCTCCCAC
TGC; Rev GGC ACC ACC TCC TGC ATA TA
IL17A (Accession: NM_002190.2) FW GAA GGC AGG AAT
CAC AAT C; Rev GCC TCC CAG ATC ACA GA
For cDNA synthesis of the adult ileum samples, the high-
capacity cDNA archive kit (Applied Biosystems) was used. PCR
was performed using the SYBR Green I master mix (Roche) for
LightCycler 480 Instrument II (Roche).
Quantiﬁcationof expression levelswas performedwithLinReg-
PCR software (Ruijter et al., 2009). All reactions were performed
in duplicate were normalized using 18S rRNA expression levels
and expressed in arbitrary units.
Speciﬁc primers were as follows:
18S rRNA FW: AAT CTG GAG CTG GCC TTT CA; Rev CTG
GAA GAT CTG CAG CCT TT
STATISTICAL ANALYSIS
Samples were analyzed by Mann–Whitney U tests in SPSS PASW
17.0.2. p-Values<0.05 were considered signiﬁcant.
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